These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Witt MA; Katz PH; Witt DJ Clin Infect Dis; 2012 Jun; 54(12):1730-5. PubMed ID: 22423127 [TBL] [Abstract][Full Text] [Related]
65. T-cell immune responses to Bordetella pertussis infection and vaccination. Fedele G; Cassone A; Ausiello CM Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26242279 [TBL] [Abstract][Full Text] [Related]
66. Human Immune Responses to Pertussis Vaccines. Ausiello CM; Mascart F; Corbière V; Fedele G Adv Exp Med Biol; 2019; 1183():99-113. PubMed ID: 31342460 [TBL] [Abstract][Full Text] [Related]
67. Using computer simulations to compare pertussis vaccination strategies in Australia. Hethcote HW; Horby P; McIntyre P Vaccine; 2004 Jun; 22(17-18):2181-91. PubMed ID: 15149775 [TBL] [Abstract][Full Text] [Related]
68. Roads to the development of improved pertussis vaccines paved by immunology. Brummelman J; Wilk MM; Han WG; van Els CA; Mills KH Pathog Dis; 2015 Nov; 73(8):ftv067. PubMed ID: 26347400 [TBL] [Abstract][Full Text] [Related]
69. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1. Feunou PF; Kammoun H; Debrie AS; Mielcarek N; Locht C Vaccine; 2010 Oct; 28(43):7047-53. PubMed ID: 20708998 [TBL] [Abstract][Full Text] [Related]
70. Pertussis outbreak in an elementary school with high vaccination coverage. Khetsuriani N; Bisgard K; Prevots DR; Brennan M; Wharton M; Pandya S; Poppe A; Flora K; Dameron G; Quinlisk P Pediatr Infect Dis J; 2001 Dec; 20(12):1108-12. PubMed ID: 11740314 [TBL] [Abstract][Full Text] [Related]
72. Are vaccination programs and isolate polymorphism linked to pertussis re-emergence? Godfroid F; Denoël P; Poolman J Expert Rev Vaccines; 2005 Oct; 4(5):757-78. PubMed ID: 16221076 [TBL] [Abstract][Full Text] [Related]
73. Functional Programming of Innate Immune Cells in Response to Bordetella pertussis Infection and Vaccination. Gillard J; van Schuppen E; Diavatopoulos DA Adv Exp Med Biol; 2019; 1183():53-80. PubMed ID: 31432398 [TBL] [Abstract][Full Text] [Related]
74. The epidemiological situation of pertussis in the Federal Republic of Germany. Finger H; Wirsing von König CH; Tacken A; Wassilak SG Dev Biol Stand; 1991; 73():343-55. PubMed ID: 1778329 [TBL] [Abstract][Full Text] [Related]
75. Pertussis--a re-emerging infection? Fung KS; Yeung WL; Wong TW; So KW; Cheng AF J Infect; 2004 Feb; 48(2):145-8. PubMed ID: 14720490 [TBL] [Abstract][Full Text] [Related]
76. Rationale for pertussis booster vaccination throughout life in Europe. Zepp F; Heininger U; Mertsola J; Bernatowska E; Guiso N; Roord J; Tozzi AE; Van Damme P Lancet Infect Dis; 2011 Jul; 11(7):557-70. PubMed ID: 21600850 [TBL] [Abstract][Full Text] [Related]
77. Bordetella pertussis epidemiology and evolution in the light of pertussis resurgence. Sealey KL; Belcher T; Preston A Infect Genet Evol; 2016 Jun; 40():136-143. PubMed ID: 26932577 [TBL] [Abstract][Full Text] [Related]
78. Vaccine efficacy and control measures in pertussis. Palmer SR Arch Dis Child; 1991 Jul; 66(7):854-7. PubMed ID: 1863099 [TBL] [Abstract][Full Text] [Related]